Vectorworks Expands Platform With Morpholio Mobile Apps Acquisition

BenzingaBenzinga
|||1 min read
Key Takeaway

Vectorworks acquires Morpholio's mobile design apps to strengthen its platform across desktop and mobile workflows for design professionals.

Vectorworks Expands Platform With Morpholio Mobile Apps Acquisition

Vectorworks, Inc., a subsidiary of the Nemetschek Group, has completed the acquisition of Morpholio, a developer of mobile design applications for iPad and iPhone. The transaction brings three established mobile tools—Trace, Board, and Journal—into Vectorworks' product portfolio, strengthening the company's position across both desktop and mobile design workflows.

The acquisition integrates Morpholio's mobile-first design capabilities with Vectorworks' established computer-aided design and building information modeling platform. This combination enables design professionals to transition between conceptual sketching and detailed execution on a unified technology stack, addressing the workflow needs of architects, designers, and engineering professionals who work across multiple devices.

Vectorworks indicated that the integration will leverage artificial intelligence features and expand its overall product ecosystem. The move reflects ongoing industry consolidation as design software providers seek to offer comprehensive solutions that span ideation, execution, and presentation phases of professional design work.

Source: Benzinga

Back to newsPublished Feb 17

Related Coverage

Benzinga

Mountain Commerce Bancorp Clears Regulatory Hurdles for Home BancShares Merger

Mountain Commerce Bancorp receives Federal Reserve and Arkansas regulatory approvals for merger with Home BancShares, expected to close in early Q2 2026.

HOMBMCBI
Benzinga

Smithfield Foods Surges on Robust Q4 Earnings, Nathan's Famous Deal

Smithfield Foods beat Q4 expectations with 83-cent EPS, announced $450M Nathan's Famous acquisition at $102/share, projecting $1.3-$1.5B FY26 operating profit. Stock surged 4.13%.

SFDNATH
Benzinga

Gilead Bolsters Inflammation Arsenal With $1.675B Ouro Medicines Deal

Gilead acquires Ouro Medicines for $1.675B upfront, targeting inflammation pipeline expansion. Galapagos NV partners to co-develop lead asset OM336.

GILDACLXGLPG
Benzinga

Vertiv Accelerates Capacity Push to Capitalize on AI Data Center Boom

Vertiv expands manufacturing capacity across three facilities and acquires ThermoKey to meet soaring AI data center demand for cooling and power infrastructure.

VRTAIPO
Benzinga

SEALSQ to Acquire Quantum Interconnect Firm Miraex in Strategic Stack Play

SEALSQ signs Letter of Intent to acquire Swiss quantum interconnect firm Miraex, completing its quantum technology stack and supporting space-based quantum infrastructure initiative.

LAESWKEY
Benzinga

VGTEL Eyes Health-Tech Acquisition From 4biddenknowledge in Strategic Bell Rose Deal

VGTEL enters formal discussions with Bell Rose Capital to acquire a pre-revenue health-tech app, with due diligence underway and potential advisory role for Bell Rose's president.

VGTLBELR